
Journal of Organometallic Chemistry p. 299 - 302 (1996)
Update date:2022-08-05
Topics:
Herrmann, Wolfgang A.
Rauch, Monika U.
Roesky, Peter W.
Di(4-t-butylpyridine)dichloromethyloxorhenium(V) (1) is obtained by reductive halogenation of methyltrioxorhenium(VII) in the presence of t-butylpyridine. A number of new methylrhenium(V) complexes can be synthesized by substitution of the halide and/or pyridine ligands, e.g. with chelating N-and P-bases or Schiff base ligands. The new rhenium complexes exhibit an asymmetric coordination of the ligands.
Nanjing Manhay Medical Technology Co.,Ltd
Contact:86-25-18061468449 13951924040
Address:Building5,Fuzhong Park,Xuanwu District
Onlychem (Jinan)Biotech Co.,Ltd
Contact:86-531-83175885
Address:No. 44, Honglou South Road, Jinan,China
Nanjing Chemzam Pharmtech Co., Ltd.
Contact:+86-25-86462165,+86-13915979898
Address:C5-1,6 Maiyue Road,Maigaoqiao,Nanjing,Jiangsu,China
Dalian Synco Chemical Co., Ltd.
Contact:+86-411-83635150
Address:Rm 1004, 24, Tangshan Street, Dalian
chengdu firsterchem Pharmaceutical Co., Ltd.
Contact:028-66825849
Address:chengdu
Doi:10.1039/c3ra21556c
(2013)Doi:10.1002/pola.26262
(2012)Doi:10.1002/(SICI)1099-1344(199605)38:5<483::AID-JLCR853>3.0.CO;2-O
(1996)Doi:10.1002/cbic.201800673
(2019)Doi:10.1039/J19680000332
(1968)Doi:10.1016/j.bmcl.2010.08.018
(2010)